|
´ëÇѰáÇÙ ¹× È£Èí±âÇÐȸ
Á¦13Â÷ õ½Ä¿¬±¸È¸ · COPD¿¬±¸È¸ °øµ¿ ½ÉÆ÷Áö¾ö
• ÀÏ ÀÚ : 2017³â 2¿ù 18ÀÏ(Åä)
• Àå ¼Ò : °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç
13 : 30 ~ 13 : 50 µî ·Ï
13 : 50 ~ 13 : 55 °³ ȸ »ç Àα¤È£ õ½Ä¿¬±¸È¸Àå
13 : 55 ~ 14 : 00 Ãà »ç ±è¿µ±Õ ´ëÇѰáÇÙ ¹× È£Èí±âÇÐȸ ÀÌ»çÀå
»çȸ : ¹Ú¿ë¹ü
1ºÎ Phenotype in Airway Disease ÁÂÀå : Àα¤È£
14 : 00 ~ 14 : 30 What Are the COPD Phenotypes/Endotypes Relevant for
Clinical Practice?
±èÀ¯ÀÏ(Àü³²ÀÇ´ë ³»°ú)
14 : 30 ~ 15 : 00 What Are the Asthma Phenotypes/Endotypes Relevant for
Clinical Practice?
±è´ö°â(¼¿ïÀÇ´ë ³»°ú)
15 : 00 ~ 15 : 30 Severe Asthma: Lessons Learned from Global Studies
Çã±Ô¿µ(°í·ÁÀÇ´ë ³»°ú)
15 : 30 ~ 15 : 50 Coffee Break
2ºÎ Update of Airway Disease ÁÂÀå : ¾ÈÁßÇö
15 : 50 ~ 16 : 20 In What Patients Should I Use Fixed LABA-LAMA
Combination in COPD ?
¾ö¼öÁ¤(µ¿¾ÆÀÇ´ë ³»°ú)
16 : 20 ~ 16 : 50 In What Patients Should I Use LAMA in Asthma ?
¹ÚÇýÀ±(¼º±Õ°üÀÇ´ë ³»°ú)
16 : 50 ~ 17 : 20 Update GOLD 2017
Á¤Áö¿¹(¿¬¼¼ÀÇ´ë ³»°ú)
17 : 20 ~ 17 : 30 Æó ȸ »ç ¾ÈÁßÇö COPD¿¬±¸È¸Àå
|